Summary Angiogenesis is thought to be an important factor for tumour growth and metastatic spread, and microvessel counts may provide useful prognostic information for several tumour types. To investigate the prognostic impact of angiogenesis in endometrial carcinoma patients, the intratumour microvessel density, which was determined immunohistochemically, has been related to survival. Sixty patients with endometrial carcinoma with long (median 19 years) and complete follow-up have been studied. Patients with increased mean microvessel density (MVDmean > 68 mm-2) had a significantly shorter 5-year survival compared with the rest (57% vs 90%, P = 0.004). In multivariate survival analyses, MVDmean had an independent prognostic impact (P = 0.03) when FIGO stage, histological type, histological grade as well as nuclear p53 protein expression was adjusted for. These findings indicate that intratumour microvessel density may contribute additional prognostic information to that obtained from the known risk factors and may be helpful in identifying endometrial carcinoma patients at high risk for disease progression.
Angiogenesis is of crucial importance for tumour growth and development of metastases (Folkman, 1989 ; Hanahan and Folkman, 1996) . Tumour cells capable of rapid proliferation are thought to be dependent on persistent blood vessels to expand, and the absence of neovascularization will consequently restrict tumour growth (Folkman, 1989) . Vascularization is likewise considered to permit shedding of cells from a primary tumour to distant body sites, thus facilitating the metastatic process (Weidner, 1995) . From experimental models, it seems evident that the angiogenic switch occurs early in the process of tumorigenesis (Hanahan and Folkman, 1996) , with the induction of angiogenesis as a discrete component of the tumour phenotype activated during the early stages. The intensity of tumour vascularization is thought to reflect the angiogenic activity generated by the neoplastic cells or the supporting stroma (Weidner et al, 1992; Holmgren et al, 1995) .
Studies of breast, lung and prostate cancer as well as other tumour types have indicated that increased microvessel density within the tumours is associated with the metastatic potential, and in some studies increased vascularity has been identified as a prognostic factor (Weidner et al, 1991 (Weidner et al, , 1992 Gasparini et al, 1994; Fontanini et al, 1995; Weidner, 1995) . In the endometrium, malignancy and increased tumour stage was associated with increased microvessel density (Abulafia et al, 1995) . A comparison of primary tumour vascularity among patients with and without recurrent disease indicated a potential prognostic importance, although the number of patients was low (Kirschner et al, 1996) .
To our knowledge, the present study is the first relating microvessel density to survival for endometrial carcinoma patients in comparison with other clinicopathological variables and p53 protein expression, which has recently been implicated as a Correspondence to: HB Salvesen regulatory factor for vascular proliferation (Dameron et al, 1994) . Our results indicate that microvessel density may provide important prognostic information for this group of patients.
MATERIALS AND METHODS
A prospective study of prognostic factors for endometrial carcinoma patients was started in January 1981 at the Department of Gynaecology and Obstetrics at Haukeland University Hospital in Norway. This is a referral hospital for patients in Hordaland county with approximately 400 000 inhabitants (about 10% of the total Norwegian population). In 1981-85, data regarding patient characteristics and treatment was collected for 60 patients primarily treated by surgery for endometrial carcinoma at Haukeland University Hospital. The treatment protocol for the period was abdominal hysterectomy and bilateral salpingoophorectomy as initial treatment. After primary operation, 54 (90%) of the patients had no residual tumour. No patient received preoperative radiation therapy. Adjuvant radiation therapy was given to patients with myometrial tumour infiltration without distant metastases, intravaginal radiation to patients with highly and moderately differentiated tumours infiltrating less than half of the myometrium and pelvic external radiation (50 Gy) to the rest of the patients. Advanced age or intercurrent disease, however, resulted in a less aggressive treatment among 14 patients. The median age at time of primary operation was 66 years (range 37-86 years). All patients were retrospectively staged according to the FIGO 1988 criteria (Mikuta, 1993) . The tumour specimens were reclassified and graded by one pathologist (LAA) according to WHO 1994 (Scully et al, 1994 .
Patient selection
Patient age, FIGO stage, treatment and survival were compared for the patients from Haukeland University Hospital included in this study with the rest of the patients from Hordaland county treated for endometrial carcinoma in the period. Curative surgical treatment was more often possible in the study group than in the rest of the population, which is in accordance with the current practice in the region, i.e. that women not available for curative treatment either because of advanced age or serious intercurrent or extensive disease are less often referred to the University Hospital for primary surgery. Except for this, there were no significant differences in the other patient characteristics. Among the patients treated for cure, no significant difference in survival was found for the study group from Haukeland University Hospital compared with the rest of the patients in the county of Hordaland.
Immunohistochemistry
Immunohistochemical staining was performed on formalin-fixed, paraffin-embedded specimens. Haematoxylin and eosin-stained sections were used to select a representative, invasive area of the tumour, and 5-jm-thick sections were stained immunohistochemically.
After protease-induced epitope retrieval, the vessels were highlighted by staining endothelial cells for factor VIII-related antigen (code no. A-082, Dako, Copenhagen) according to the standardized avidin-biotin method provided by the manufacturer.
For p53 staining, the sections were subjected to microwave epitope retrieval (750 W, 2 x 5 min in citrate buffer, pH 6) before staining with the monoclonal antibody DO-7 (code no. M-7001, Dako) according to the avidin-biotin method.
The extent of nuclear p53 staining was recorded by a semiquantitative and subjective grading, considering both the intensity of staining and the proportion of cells showing an unequivocal positive reaction as described previously (Aas et al, 1996) . Intensity was recorded as 0 (no staining) to 3 (strong staining), percentage of nuclear staining as 0 (no tumour cells positive), 1 (<10% of the tumour cells), 2 (positive staining in 10-50% of the tumour cells) and 3 (positive staining in >50% of the tumour cells). A staining index was calculated as the product of the staining intensity and the staining area.
The slides were counterstained with Harris haematoxylin. Blinded for patient characteristics and outcome, the slides were evaluated individually by two of the authors (HS, LAA) in a standard light microscope for immunohistochemical staining.
Vessel counts
The invasive tumours were often heterogeneous with respect to the amount and distribution of microvessels, and the sections were scanned at low magnifications (x40 and xlOO) to identify the most vascular area of the tumour ('hot spot'). Within these areas, a minimum of ten fields at x250 magnification (0.4243 mm2 per field) were examined. Brown-stained endothelial cells or endothelial cell clusters that were clearly separate from adjacent vessels, tumour cells or connective tissue elements were considered to be single countable microvessels, as previously described by Weidner et al (1991, 1995) . The maximum count within any single field (MVDmaX), the average of the three most vascular fields (MVDmean3) and the average of all fields examined within the 'hot spot' areas (MVDmeaw) were then recorded and expressed as counts mm-2 as previously described (Paulsen et al, 1997) . MVDmean was considered to represent the average tumour vascularity of the 'hot spot' areas.
Each slide was examined three times blinded for previous results (HS). (Cox, 1972 MVDmean3 and MVDmean all express microvessel density and are strongly correlated, they were introduced separately into the multivariate model with the traditional clinicopathological variables for estimation of hazard ratios as a measure of effect. Data were analysed using the Biomedical Computer Programs (BMDP) (Dixon, 1992) . MVDmean (P = 0.004), MVDmean3 (P = 0.01) and MVDmax (P = 0.01), whereas there was no difference between the other three categories (Figure 1) . In later analyses, the patients were therefore divided in two groups by the upper quartile ( (Table 2 ).
RESULTS
In multivariate analyses of survival, MVDmean was an independent prognostic factor (P = 0.03) when adjusted for FIGO stage, histological type, histological grade and nuclear p53 protein expression. MVDmaX' MVDmean3 and MVD mean were all analysed separately in the multivariate models, and MVDmean was found to be the strongest prognostic factor. Independent prognostic impact was also found for FIGO stage (P = 0.0001), whereas nuclear p53 protein expression showed a borderline influence (P = 0.08). Histological grade (P = 0.20) and histological type (P = 0.29) lost their prognostic influence in the final multivariate analysis. However, when only tumour variables were included in the Cox analysis, MVDmean' p53 protein expression and histological type remained as significant and independent predictors of survival (Table 3 ).
DISCUSSION
Our finding that increased microvessel count is significantly associated with decreased survival is in accordance with studies on other cancer forms, particularly breast cancers (Weidner et al, 1991 (Weidner et al, , 1992 Gasparini et al, 1994; Fontanini et al, 1995; Weidner, 1995) . The absolute microvessel counts mm-2 for endometrial carcinomas are somewhat lower than those reported for breast tumours, using the same method (Weidner et al, 1991) . This could reflect a biological difference between endometrial and breast carcinomas. However, the microvessel counts in our study seem to be higher than those reported by Kirschner et al (1996) in a small study of endometrial carcinomas, although different techniques were used.
The significant association between microvessel density and metastatic disease demonstrated in our study has been reported for other cancer types (Weidner et al, 1991 (Weidner et al, , 1992 (Weidner et al, , 1993 Gasparini et al, 1994; Fontanini et al, 1995; Weidner, 1995) . These results are in accordance with angiogenesis being a crucial factor in the metastatic process and thus for the progression of a malignant disease (Folkman, 1989) . The regulatory role of p53 on angiogenesis has been discussed recently (Dameron et al, 1994) . In an experimental model using fibroblasts, it has been shown that altered p53 may reduce the British Journal of Cancer (1998) 77(7), 1140-1144 10- expression of thrombospondin-1, which is a potent inhibitor of vessel formation (Dameron et al, 1994) . Further, p53 mutations have been related to induction of vascular endothelial growth factor (VEGF) expression (Kieser et al, 1994) . In our present study, no significant association between nuclear p53 protein expression and microvessel density was present, which is in accordance with reports on breast cancer (Gasparini et al, 1994; Costello et al, 1995; Paulsen et Kj0rstad, 1991; Rose, 1996) .
These factors have been extensively studied (Mikuta, 1993) , and our present findings generally support the view that FIGO stage, as revised in 1988, is a highly significant prognosticator. Recently, molecular markers have been introduced as potential prognostic factors that could improve our ability to identify high-risk patients with endometrial carcinoma (Pisani et al, 1995) . P53 protein expression has been shown to be an independent prognostic factor in some studies (Ito et al, 1994; Pisani et al, 1995; Geisler et al, 1996; Soong et al, 1996) , while others have been unable to confirm this (Inoue et al, 1994; Lukes et al, 1994; Reinartz et al, 1994) . We found a significant prognostic influence of nuclear p53 protein expression when only tumour variables were investigated, whereas p53 staining showed a borderline significance in the multivariate analysis with FIGO stage included. The relatively small number of patients in this study should, however, be kept in mind.
In conclusion, our findings suggest that microvessel density may be a helpful tool to identify endometrial carcinoma patients at higher risk of death. The increasing optimism regarding the use of angiogenesis inhibitors (Baillie et al, 1995; Hanahan and Folkman, 1996) may further motivate the quantitation of intratumour microvessel density for decisions regarding therapeutic strategies.
